276 related articles for article (PubMed ID: 413839)
1. Inhibition of platelet prostaglandin synthetase by oral aspirin.
Burch JW; Stanford N; Majerus PW
J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
[TBL] [Abstract][Full Text] [Related]
2. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.
Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D
J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles.
Majerus PW; Stanford N
Br J Clin Pharmacol; 1977 Feb; 4 Suppl 1(Suppl 1):15S-18S. PubMed ID: 406909
[TBL] [Abstract][Full Text] [Related]
5. Implications of hepatic and extrahepatic metabolism of aspirin in selective inhibition of platelet cyclooxygenase.
Roberts MS; Cossum PA; Kilpatrick D
N Engl J Med; 1985 May; 312(21):1388-9. PubMed ID: 3921841
[No Abstract] [Full Text] [Related]
6. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
Pedersen AK; FitzGerald GA
N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.
Roth GJ; Majerus PW
J Clin Invest; 1975 Sep; 56(3):624-32. PubMed ID: 1159076
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of interaction of acetylsalicylic acid and indomethacin with endoperoxide prostaglandin synthetase].
Muratov VK; Igumnova ND; Basevich VV; Churiukanov VV; Mevkh AT
Farmakol Toksikol; 1983; 46(5):44-8. PubMed ID: 6414841
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
Crook D; Collins AJ
Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
[No Abstract] [Full Text] [Related]
12. Low-dose aspirin is a selective inhibitor of platelet cyclooxygenase activity in healthy subjects.
Patrignani P; Filabozzi P; Patrono C
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():259-64. PubMed ID: 6221533
[No Abstract] [Full Text] [Related]
13. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
Halushka MK; Walker LP; Halushka PV
Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
[TBL] [Abstract][Full Text] [Related]
15. Radioimmune assay of human platelet prostaglandin synthetase.
Roth GJ; Machuga ET
J Lab Clin Med; 1982 Feb; 99(2):187-96. PubMed ID: 6801166
[TBL] [Abstract][Full Text] [Related]
16. Assessing aspirin-induced attenuation of platelet reactivity by flow cytometry.
Hübl W; Assadian A; Lax J; Meixner U; Fang IF; Hagmüller G; Panzer S; Bayer PM
Thromb Res; 2007; 121(1):135-43. PubMed ID: 17467777
[TBL] [Abstract][Full Text] [Related]
17. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.
Cerletti C; Gambino MC; Garattini S; de Gaetano G
J Clin Invest; 1986 Jul; 78(1):323-6. PubMed ID: 3088044
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid metabolism and inhibition of cyclooxygenase in platelets from asthmatic subjects with aspirin intolerance.
Bonne C; Moneret-Vautrin DA; Wayoff M; Descharmes A; Gazel P; Legrand A; Kalt C
Ann Allergy; 1985 Feb; 54(2):158-60. PubMed ID: 3918485
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of prostaglandin synthase by aspirin.
Roth GJ; Stanford N; Majerus PW
Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3073-6. PubMed ID: 810797
[TBL] [Abstract][Full Text] [Related]
20. [Demonstration of specific platelet function anomaly in asthma induced by aspirin: diagnostic consequences].
Ameisen JC; Joseph M; Tonnel AB; Vorng H; Pancré V; Fournier E; Wallaert B; Capron A
C R Acad Sci III; 1985; 300(4):137-42. PubMed ID: 3919888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
